Agape ATP Corp ATPC
ATP Corporation operates through its subsidiaries, namely, Agape ATP Corporation ("AATP LB"), a company incorporated in Labuan,
Malaysia, and Agape Superior Living Sdn. Bhd. ("ASL"), a company incorporated in Malaysia on August 8, 2003.
LB is an investment holding company with 100% equity interest in Agape ATP International Holding Limited ("AATP HK"), a company
incorporated in Hong Kong.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by segment
- Skin Care Health And Wellness Segment
- Green Energy Segment
| Segment | FY2025 | FY2024 |
|---|---|---|
| Skin Care Health And Wellness Segment | $1.4M | $1.3M |
| Green Energy Segment | $139.7K | $42.8K |
As the company reported it, from the “SCHEDULE OF REPORTING SEGMENTS (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | $1.4M | $1.9M | $1.0M | $3.4M | $1.3M | $487.0K | — | — |
| Cost of revenue | $686.0K | $563.6K | $494.5K | $666.0K | $297.3K | $775.9K | $1.2M | $441.4K | — | — |
| Gross profit | $838.3K | $759.1K | $936.6K | $1.2M | $719.6K | $2.7M | $89.3K | $45.6K | — | — |
| SG&A | $3.8M | $3.1M | $2.4M | $2.0M | $1.7M | $1.6M | $396.0K | $279.7K | $75.4K | — |
| Total operating expenses | $4.1M | $3.3M | $3.1M | $2.7M | $2.6M | $2.8M | $403.9K | -$14.0K | — | — |
| Operating income | -$3.3M | -$2.6M | -$2.1M | -$1.5M | -$1.9M | -$158.1K | -$314.6K | -$234.1K | — | — |
| Pre-tax income | -$2.3M | -$2.5M | -$2.1M | -$1.7M | -$2.4M | $516.3K | -$723.1K | -$124.9K | -$75.4K | — |
| Income tax | $2.3K | $4.9K | $3.6K | $4.1K | $137.1K | $161.6K | $7.0K | $5.3K | — | — |
| Net income | -$2.3M | -$2.5M | -$2.1M | -$1.7M | -$2.5M | $354.8K | -$716.1K | -$130.3K | -$75.4K | — |
| EPS, basic | -2.85 | -31.74 | -0.55 | -0.02 | -0.01 | 0.00 | — | — | — | — |
| EPS, diluted | -2.85 | -31.74 | -0.55 | -0.02 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Shares, diluted (wtd. avg.) | 801,081 | 77,839 | 3.8M | 87.8M | 376.2M | 376.4M | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $140.1K | $2.0M | $4.8M | $1.4M | $2.6M | $3.5M | $2.7M | $3.5M | $2.3M | $10 |
| Receivables | $12.3K | $53.7K | $55.5K | $2.8K | — | $172.8K | $433.3K | — | — | — |
| Inventory | $27.4K | $46.3K | $47.9K | $46.3K | $375.5K | $589.8K | — | — | — | — |
| Total current assets | $24.3M | $2.8M | $5.2M | $2.0M | $3.9M | $5.7M | $3.5M | $4.0M | $2.3M | — |
| Property, plant and equipment | $14.6K | $31.5K | $77.9K | $142.1K | $215.8K | $298.3K | — | — | — | — |
| Other intangibles | $9.5K | $13.1K | $17.5K | $24.0K | $3.7K | $5.8K | — | — | — | — |
| Total assets | $24.6M | $3.2M | $5.7M | $2.8M | $4.7M | $7.2M | $4.3M | $5.2M | $2.3M | — |
| Total current liabilities | $2.1M | $1.1M | $1.1M | $1.2M | $1.3M | $1.0M | $84.0K | $241.8K | $8.1K | — |
| Total liabilities | $2.2M | $1.3M | $1.4M | $1.2M | $1.4M | $1.3M | $84.0K | $241.8K | $8.1K | — |
| Retained earnings | -$11.8M | -$9.5M | -$7.0M | -$4.9M | -$3.3M | -$734.4K | -$1.1M | -$373.1K | -$100.4K | — |
| Total equity | $22.5M | $1.9M | $4.4M | $1.6M | $3.3M | $5.9M | $4.3M | $5.0M | $2.3M | -$25.0K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.4M | -$2.7M | -$2.0M | -$811.7K | -$845.8K | -$558.0K | -$704.4K | -$348.0K | -$100.3K | — |
| Depreciation and amortisation | $20.2K | $52.6K | $70.3K | $71.8K | $75.8K | $55.4K | — | — | — | — |
| Capital expenditure | — | — | — | — | $4.0K | $4.7K | — | — | — | — |
| Investing cash flow | -$23.0M | -$50.0K | -$17.3K | -$32.1K | -$4.0K | $1.3M | -$1.5K | -$1.4M | — | — |
| Financing cash flow | $23.5M | -$11.9K | $5.4M | -$234.5K | -$19.1K | -$22.1K | -$4.6K | $2.9M | $2.4M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-016297.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $487.0K | $1.3M | $3.4M | $1.0M | $1.9M | $1.4M | $1.3M | $1.5M |
| Gross profit | — | — | $45.6K | $89.3K | $2.7M | $719.6K | $1.2M | $936.6K | $759.1K | $838.3K |
| Net income | — | -$75.4K | -$130.3K | -$716.1K | $354.8K | -$2.5M | -$1.7M | -$2.1M | -$2.5M | -$2.3M |
Recent filings and events
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Delisting notice The exchange has told the company it no longer meets the rules for staying listed - usually price, market cap, or filings that are late. Item 3.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Shareholder rights changed The terms attaching to the shares themselves have changed. Item 3.03
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Delisting notice Item 3.01
- Regulation FD disclosure Item 7.01
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Delisting notice Item 3.01
- Material agreement signed Item 1.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 8000
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| LFST | LifeStance Health Group, Inc. | $4.94B | — | 13.9% |
| PRVA | Privia Health Group, Inc. | $2.86B | 124.5x | 22.3% |
| WGS | GeneDx Holdings Corp. | $1.67B | — | 40.0% |
| PNTG | Pennant Group, Inc. | $1.46B | 49.9x | 36.3% |
| USPH | U S PHYSICAL THERAPY INC /NV | $1.32B | 62.3x | 16.3% |
| INNV | InnovAge Holding Corp. | $1.30B | — | 11.8% |
| OMDA | Omada Health, Inc. | $1.16B | — | 53.2% |
| SRTA | Strata Critical Medical, Inc. | $412.3M | 9.3x | 34.3% |